AELF FlightService
4.12.2023 16:02:10 CET | ACCESS Newswire | Press release
CHICAGO, IL / ACCESSWIRE / December 4, 2023 / AELF announced today that it has welcomed Alexander "AJ" Issenman to the company as Director of Capital Markets. Issenman joins AELF from Seabury Capital, where he served as a Director at Seabury Capital Management focusing on merchant banking and capital markets transactions across the aviation, aerospace and defense sectors within the merchant banking and capital markets group.
"We are grateful to add AJ to our team as we seek to broaden the reach of our leasing business," said Victoria Ricks, spokesperson for AELF. "AJ's background and experience make him a great addition to the strategic growth of our portfolio of leased aircraft."
AELF owns and leases a fleet of A330s which include a mix of high-density seating, dual-class seating, and light cargo configurations. This year the company has begun expanding its investment in 737-800s.
"I'm eager to get into the market with all that AELF has to offer," said Issenman. "The company's unique capabilities, creative and nimble approach, offer a lot to airlines and other partners in the industry. I'm excited by all that can be achieved in this new role."
AELF reports it will seek to put capital resources to work with the acquisition of aircraft subject to lease. "For several years we have focused on acquiring dormant aircraft and sourcing new lessees. With AJ coming aboard, we're expanding our focus, and leveraging the experience of our team and Board," Ricks said.
"With significant available capital resources and comfort in acquiring "stub leases" or dormant aircraft, AELF is a perfect partner for fleet phase outs or the sale lease back of a specific aircraft type from an airline's fleet plan," Issenman said.
About the AELF Group
Aircraft Engine Lease Finance Inc. ("AELF"), which also conducts business as AELF FlightService, is an experienced leader in commercial aircraft leasing, finance, and air transport solutions for cargo and passengers. AELF is also a shareholder in widebody ACMI operator MalethAero AOC Limited. The group offers a full spectrum of services ranging from long-term operating leases, sale leasebacks and finance sales, as well as short and long-term ACMI contracts. It is unique in its ability to offer wet-to-dry leasing arrangements that enable airlines to test out new routes under Maleth's operation before embarking on a dry lease with AELF, and unique ACMI partnerships allowing lessors to put their dormant aircraft into revenue service temporarily or long-term, among other custom solutions. Learn more at AELF-FlightService.com. For the latest updates, follow us on LinkedIn, and Instagram.
Contact Information
Helena Padilla Siles
Communications Manager
hpadillasiles@aelf-flightservice.com
SOURCE: AELF FlightService
To view this piece of content from stats.newswire.com, please give your consent at the top of this page.View source version on accesswire.com:
https://www.accesswire.com/812860/aj-issenman-joins-aelf-flightservice-as-director-of-capital-markets
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
UK-Based Vesalic Limited Emerges from Stealth with Landmark Discovery of Potential Non-CNS Driver of Motor Neuron Diseases, including ALS, and Breakthrough Therapeutic and Diagnostic Opportunities9.2.2026 06:00:00 CET | Press release
This groundbreaking discovery has revealed a systemic metabolic dysfunction that creates a toxic exosome cargo in ALS patients, which is carried to the CNS, where it binds to and damages neurons Vesalic is pioneering a novel therapeutic to intercept and neutralise these toxins, potentially slowing or halting progression of monogenic and sporadic forms of ALS In addition, Vesalic has discovered a disease-specific alteration of the lipid composition in the membranes of exosomes circulating in the blood, and has developed a highly accurate biomarker-based technology to detect both monogenic and sporadic ALS Based on its novel biomarker discoveries, Vesalic is also applying its biomarker technology for other neurodegenerative diseases, including Alzheimer's and Parkinson's LONDON, UK / ACCESS Newswire / February 9, 2026 / Vesalic Limited, an early-stage neurodegenerative disease-focused biotech company, today emerged from stealth with the landmark discovery of a systemic process - largely
Innodata to Report Fourth Quarter and Fiscal Year 2025 Results5.2.2026 14:30:00 CET | Press release
NEW YORK, NY / ACCESS Newswire / February 5, 2026 / INNODATA INC. (Nasdaq:INOD) today announced that it will report Fourth Quarter and Fiscal Year 2025 results after the market closes on Thursday, February 26, 2026. A news release will be available in both the News and Investor Relations sections of the Innodata website, www.innodata.com. Innodata has scheduled an investor conference call for 5:00 PM Eastern time on that same day. The call-in numbers for the conference call are: (+1) 800 549 8228 North America (+44) 800 279 7040 United Kingdom (+1) 289 819 1520 International Participant Access Code 27117 # Replay dial-In (+1) 888 660 6264 North America (+1) 289 819 1325 International: Replay Passcode 27117 # Investors are also invited to access a live Webcast of the conference call at the Investor Relations section of Innodata's website at https://investor.innodata.com/events-and-presentations/. Please note that the Webcast feature will be in listen-only mode. Call-in replay will be av
Datavault AI Chief Executive Officer and President Issues Letter to Stockholders Highlighting 2025 Accomplishments and Outlook for 20265.2.2026 12:00:00 CET | Press release
Datavault AI signed $49M of Tokenization and Technology Licensing agreements in Q4'25 that impact FY2025 and FY2026 Revenue. Revenue: Datavault AI expects at least $30 million in revenue for FY2025, compared to $2.7 million in FY2024. This represents an increase of more than 1,000% growth in our revenue over 2024. The Company continues to expand to drive substantial near- and long-term accretion to our cash flows and earnings with a revenue target for 2026 of at least $200 million. PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / February 5, 2026 / Datavault AI Inc. (NASDAQ:DVLT) ("Datavault AI" or the "Company"), a leader in data monetization, credentialing, digital engagement and real-world asset (RWA) tokenization technologies, today issued a letter from Nathaniel Bradley, its Chief Executive Officer, to its stockholders highlighting the Company's accomplishments in 2025 and its outlook for 2026. A MESSAGE FROM OUR CHIEF EXECUTIVE OFFICER Dear Datavault AI Stockholders, I would like t
AGFA HealthCare Named Best in KLAS(R) 2026 Across Three Enterprise Imaging Segments in the United States4.2.2026 15:45:00 CET | Press release
Industry recognition for the third consecutive year reinforces AGFA HealthCare's clinician-first commitment, and leadership in empowering connected, high-performance imaging environments MORTSEL, BE / ACCESS Newswire / February 4, 2026 / AGFA HealthCare today announced that it has been named Best in KLAS® 2026 across three Enterprise Imaging segments in the United States, with two awards earned for the second consecutive year, underscoring the company's continued leadership in delivering clinician-first imaging solutions trusted by healthcare organizations worldwide. The recognition comes as KLAS Research marks its 30th anniversary, celebrating three decades of amplifying the voice of healthcare providers through independent, data-driven insights. AGFA HealthCare's Best in KLAS distinctions reflect strong customer validation of its Enterprise Imaging platform - designed to empower clinicians to stay in their flow, reduce complexity across imaging workflows, and enable confident clinica
Preservica Redefines Digital Preservation with Powerful Built-In AI Tools4.2.2026 15:00:00 CET | Press release
OXFORD, UK and BOSTON, MA / ACCESS Newswire / February 4, 2026 / Preservica, the leader in AI-powered Active Digital Preservation™, today announced the rollout of integrated, human-centered AI tools and flexible AI Credits across its product editions. These new features make AI assistance a seamless part of everyday archival workflows, empowering organizations of all sizes to safely adopt AI and scale its use as their needs grow. "With the sheer volume of digital content in backlogs and being created daily, using AI to assist in archival tasks has now become essential" says Stuart Reed, Chief Product Officer at Preservica "Seamlessly integrating human-centered AI tools across our product editions turns AI for Digital Preservation into reality - enabling organizations of all sizes to accelerate routine work, cut backlogs and enhance discovery." Developed in collaboration with Preservica's user community and refined through the company's highly rated AI Workshop series, these embedded to
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
